As depicted in Figure 7D, our results demonstrate that inhibiting TNS4 effectively mitigates the oncogenic features of HNSCC cells by attenuating the FAK-mediated Akt and TGFβ signaling pathways. This evidence concerns the gene TGFB1 and head and neck squamous cell carcinoma.